ALEXIS TURNER
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family HOLLAND, MI NPI 1295291870
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MI PFIZER INC. All categories
General Payments — all program years on this page
$1,855.20
- Category: General Payments
- Program years: PY2021–2024
- Record count: 84
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $891.59 across 39 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $891.59 | 39 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $107.67 | 6 |
| ABBVIE INC. | $105.27 | 4 |
| Merck Sharp & Dohme Corporation | $82.07 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $73.81 | 3 |
| EISAI INC. | $69.66 | 3 |
| E.R. Squibb & Sons, L.L.C. | $62.00 | 1 |
| Celgene Corporation | $44.22 | 2 |
| Gilead Sciences, Inc. | $36.23 | 2 |
| EMD Serono, Inc. | $35.39 | 2 |
| Astellas Pharma US Inc | $30.60 | 1 |
| Genmab U.S., Inc. | $26.64 | 1 |
| Amneal Pharmaceuticals LLC | $23.97 | 1 |
| TerSera Therapeutics LLC | $23.53 | 1 |
| SOBI, INC | $22.76 | 1 |
| BeiGene USA, Inc. | $21.77 | 1 |
| Coherus Biosciences Inc. | $21.14 | 1 |
| Genentech USA, Inc. | $19.51 | 1 |
| PharmaEssentia USA Corporation | $19.42 | 1 |
| Alnylam Pharmaceuticals Inc. | $17.06 | 1 |
| Stemline Therapeutics Inc. | $17.04 | 1 |
| Spectrum Pharmaceuticals Inc. | $16.99 | 1 |
| Acrotech Biopharma Inc. | $14.84 | 1 |
By program year
Records — PY2024 (39)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.